40.77BMarket Cap
28.42P/E TTM
Teva Pharmaceutical Industries Ltd
Key Figures
35.605Open
35.660High
4.70MVolume
28.42P/E TTM
11.22P/E Dynamic
--Dividend TTM
0.40%Turnover Ratio
35.410Prev. Close
34.560Low
77.80MTurnover
LossP/E Static
5.26P/B
0.00%Div Yield TTM
3.99%ROA
37.34552wk High
0.59Volume Ratio
-1.64BNet Profit
1.17BShares
1.2314EPS TTM
0.84Beta
21.60%ROE
14.99052wk Low
3.11%Amplitude
52.29%Gross Margin
40.77BMarket Cap
1.22Reward/Risk
1.82%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
Teva Pharmaceutical Industries Ltd's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 82 out of 155 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 38.93.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Teva Pharmaceutical Industries Ltd's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Teva Pharmaceutical Industries Ltd Highlights
StrengthsRisks
Teva Pharmaceutical Industries Ltd News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Teva Pharmaceutical Industries Ltd
TEVA
12
Indicators
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Teva Pharmaceutical Industries Ltd Info
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Ticker SymbolTEVA
CompanyTeva Pharmaceutical Industries Ltd
CEOFrancis (Richard D)
Websitehttps://www.tevapharm.com/
Shareholders
FAQs
What is the current price of Teva Pharmaceutical Industries Ltd (TEVA)?
The current price of Teva Pharmaceutical Industries Ltd (TEVA) is 35.00.
What is the symbol of Teva Pharmaceutical Industries Ltd?
The ticker symbol of Teva Pharmaceutical Industries Ltd is TEVA.
What is the 52-week high of Teva Pharmaceutical Industries Ltd?
The 52-week high of Teva Pharmaceutical Industries Ltd is 37.34.
What is the 52-week low of Teva Pharmaceutical Industries Ltd?
The 52-week low of Teva Pharmaceutical Industries Ltd is 14.99.
What is the market capitalization of Teva Pharmaceutical Industries Ltd?
The market capitalization of Teva Pharmaceutical Industries Ltd is 40.77B.
Is Teva Pharmaceutical Industries Ltd (TEVA) currently rated as Buy, Hold, or Sell?
According to analysts, Teva Pharmaceutical Industries Ltd (TEVA) has an overall rating of Buy, with a price target of 38.93.
What is the Earnings Per Share (EPS TTM) of Teva Pharmaceutical Industries Ltd (TEVA)?
The Earnings Per Share (EPS TTM) of Teva Pharmaceutical Industries Ltd (TEVA) is 1.23.
